Trademark Overview
On Tuesday, April 2, 2024, a trademark application was filed for SPROUT SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the SPROUT SOLUTIONS trademark a serial number of 98480408. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 7, 2025. This trademark is owned by National Resilience, Inc.. The SPROUT SOLUTIONS trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platforms for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology, being, biomanufacturing for others
Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to in the field of biological treatment and bioproduction; providing scientific research information, namely, the provision of information for relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services relating to for the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and...
